133 related articles for article (PubMed ID: 2687295)
1. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
Pietenpol JA; Howe PH; Cunningham MR; Leof EB
J Cell Physiol; 1989 Dec; 141(3):453-60. PubMed ID: 2687295
[TBL] [Abstract][Full Text] [Related]
2. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
Coffey RJ; Leof EB; Shipley GD; Moses HL
J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events.
Fish EN; Ghislain J; Trogadis J; Stevens JK
Cancer Res; 1993 Nov; 53(21):5148-57. PubMed ID: 7693332
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
Robinson RA; Branum EL; Volkenant ME; Moses HL
Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
[TBL] [Abstract][Full Text] [Related]
5. Modulation of epidermal growth factor receptors by gamma interferon in a breast cancer cell line.
Chakravarthy A; Chen LC; Mehta D; Hamburger AW
Anticancer Res; 1991; 11(1):347-51. PubMed ID: 1902074
[TBL] [Abstract][Full Text] [Related]
6. alpha-Interferon down-regulates epidermal growth factor receptors on renal carcinoma cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon.
Eisenkraft BL; Nanus DM; Albino AP; Pfeffer LM
Cancer Res; 1991 Nov; 51(21):5881-7. PubMed ID: 1718587
[TBL] [Abstract][Full Text] [Related]
7. Continuous maintenance of transformed fibroblasts under reduced serum conditions: utility as a model system for investigating growth factor-specific effects in nonquiescent cells.
Mulder KM; Brattain MG
J Cell Physiol; 1989 Mar; 138(3):450-8. PubMed ID: 2647770
[TBL] [Abstract][Full Text] [Related]
8. Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide.
Levine AE; McRae LJ; Brattain MG
Cancer Res; 1985 Dec; 45(12 Pt 1):6401-5. PubMed ID: 2998599
[TBL] [Abstract][Full Text] [Related]
9. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
10. Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine- and paracrine-acting mitogenic factors.
Cook PW; Pittelkow MR; Shipley GD
J Cell Physiol; 1991 Feb; 146(2):277-89. PubMed ID: 1999476
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone on the growth properties and on epidermal growth factor receptor expression in the teratoma-derived tumorigenic cell line 1246-3A.
Serrero G; Lepak NM; Hayashi J; Eisinger DP
Cancer Res; 1992 Aug; 52(15):4242-7. PubMed ID: 1638538
[TBL] [Abstract][Full Text] [Related]
12. Modulation of fibronectin synthesis and fibronectin binding during transformation and differentiation of mouse AKR fibroblasts.
Varani J; Chakrabarty S
J Cell Physiol; 1990 Jun; 143(3):445-54. PubMed ID: 2141611
[TBL] [Abstract][Full Text] [Related]
13. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
Pichon F; Seuwen K; Pouysségur J; Lagarde AE
Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
Cook PW; Ashton NM; Karkaria CE; Siess DC; Shipley GD
J Cell Physiol; 1995 May; 163(2):418-29. PubMed ID: 7706383
[TBL] [Abstract][Full Text] [Related]
15. Growth arrest of AKR-2B cells maintained in the presence of epidermal growth factor or 12-O-tetradecanoylphorbol-13 acetate: evidence for two separate G1 arrest points.
Moses HL; Proper JA; Volkenant ME; Swartzendruber DE
J Cell Physiol; 1980 Mar; 102(3):367-78. PubMed ID: 6967071
[TBL] [Abstract][Full Text] [Related]
16. Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
Levine AE; Crandall CA
Cancer Res; 1987 Aug; 47(16):4278-82. PubMed ID: 3496961
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid differentially affects platelet-derived growth factor and epidermal growth factor-regulated cell growth of mouse osteoblast-like cells.
Tsukamoto T; Matsui T; Takaishi T; Ito M; Fukase M; Chihara K
Cell Growth Differ; 1994 Feb; 5(2):207-12. PubMed ID: 8180134
[TBL] [Abstract][Full Text] [Related]
18. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-alpha, platelet-derived growth factor B, and interleukin-1 beta.
Li DQ; Tseng SC
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2068-80. PubMed ID: 8814146
[TBL] [Abstract][Full Text] [Related]
20. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
Brondyk WH; Boeckman FA; Fahl WE
Oncogene; 1991 Jul; 6(7):1269-76. PubMed ID: 1861869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
